Atosa Nejatian1, Åsa Omstedt2, Jonas Höijer3, L O Hansson4, Therese Djärv5, Kai M Eggers6, Per Svensson5. 1. Functional Area of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: atosa.nejatian@karolinska.se. 2. Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. 3. Unit of Biostatistics IMM, Karolinska Institutet, Stockholm, Sweden. 4. Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden. 5. Functional Area of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. 6. Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Abstract
BACKGROUND: Most patients with chest pain are discharged from the emergency department (ED) with the diagnosis "unspecified chest pain." It is unknown if evaluation with a high-sensitivity troponin T (hsTnT) assay affects prognosis in this large population. OBJECTIVES: The aim was to investigate whether the introduction of an hsTnT assay is associated with reduced incidence of major adverse cardiac events (MACEs) and cardiovascular (CV) risk profile in patients with chest pain discharged from the ED. METHODS: The study included 65,696 patients with "unspecified chest pain" discharged from 16 Swedish hospital EDs between 2006 and 2013 in which an hsTnT assay was introduced as the clinical routine. Patients evaluated with a conventional and an hsTnT assay were compared regarding the occurrence of 30-day MACE and CV risk profile based on information from national registries. Patients directly discharged and those discharged after an initial admission were analyzed separately. RESULTS: Fewer directly discharged patients experienced a MACE when evaluated with an hsTnT compared with a conventional assay (0.6% vs. 0.9%; odds ratio [OR]: 0.7; 95% confidence interval [CI]: 0.57 to 0.83). In contrast, more patients discharged after an initial admission experienced a MACE when evaluated with an hsTnT (7.2% vs. 3.4%; OR: 2.18; 95% CI: 1.76 to 2.72). Admitted patients had a higher general CV risk profile when evaluated with hsTnT, whereas directly discharged patients had a lower general CV risk profile with the same test. CONCLUSIONS: Patients directly discharged from the ED with unspecified chest pain experienced fewer MACEs and had a better risk profile when evaluated with hsTnT. Our findings suggest that more true at-risk patients were identified and admitted. The implementation of hsTnT assays in Swedish hospitals has improved evaluations in the ED.
BACKGROUND: Most patients with chest pain are discharged from the emergency department (ED) with the diagnosis "unspecifiedchest pain." It is unknown if evaluation with a high-sensitivity troponin T (hsTnT) assay affects prognosis in this large population. OBJECTIVES: The aim was to investigate whether the introduction of an hsTnT assay is associated with reduced incidence of major adverse cardiac events (MACEs) and cardiovascular (CV) risk profile in patients with chest pain discharged from the ED. METHODS: The study included 65,696 patients with "unspecifiedchest pain" discharged from 16 Swedish hospital EDs between 2006 and 2013 in which an hsTnT assay was introduced as the clinical routine. Patients evaluated with a conventional and an hsTnT assay were compared regarding the occurrence of 30-day MACE and CV risk profile based on information from national registries. Patients directly discharged and those discharged after an initial admission were analyzed separately. RESULTS: Fewer directly discharged patients experienced a MACE when evaluated with an hsTnT compared with a conventional assay (0.6% vs. 0.9%; odds ratio [OR]: 0.7; 95% confidence interval [CI]: 0.57 to 0.83). In contrast, more patients discharged after an initial admission experienced a MACE when evaluated with an hsTnT (7.2% vs. 3.4%; OR: 2.18; 95% CI: 1.76 to 2.72). Admitted patients had a higher general CV risk profile when evaluated with hsTnT, whereas directly discharged patients had a lower general CV risk profile with the same test. CONCLUSIONS:Patients directly discharged from the ED with unspecifiedchest pain experienced fewer MACEs and had a better risk profile when evaluated with hsTnT. Our findings suggest that more true at-risk patients were identified and admitted. The implementation of hsTnT assays in Swedish hospitals has improved evaluations in the ED.
Authors: Ziwei Lin; Swee Han Lim; Siang Jin Terrance Chua; E Shyong Tai; Yiong Huak Chan; Arthur Mark Richards Journal: Singapore Med J Date: 2019-02-18 Impact factor: 1.858
Authors: Nivethitha Ilangkovan; Hans Mickley; Axel Diederichsen; Annmarie Lassen; Thomas L Sørensen; Hussam Mahmoud Sheta; Peter B Stæhr; Christian Backer Mogensen Journal: BMJ Open Date: 2017-12-22 Impact factor: 2.692
Authors: Anoop S V Shah; Atul Anand; Fiona E Strachan; Amy V Ferry; Kuan Ken Lee; Andrew R Chapman; Dennis Sandeman; Catherine L Stables; Philip D Adamson; Jack P M Andrews; Mohamed S Anwar; John Hung; Alistair J Moss; Rachel O'Brien; Colin Berry; Iain Findlay; Simon Walker; Anne Cruickshank; Alan Reid; Alasdair Gray; Paul O Collinson; Fred S Apple; David A McAllister; Donogh Maguire; Keith A A Fox; David E Newby; Christopher Tuck; Ronald Harkess; Richard A Parker; Catriona Keerie; Christopher J Weir; Nicholas L Mills Journal: Lancet Date: 2018-08-28 Impact factor: 79.321
Authors: Marat Fudim; Andrew P Ambrosy; Jie-Lena Sun; Kevin J Anstrom; Bradley A Bart; Javed Butler; Omar AbouEzzeddine; Stephen J Greene; Robert J Mentz; Margaret M Redfield; Yogesh N V Reddy; Muthiah Vaduganathan; Eugene Braunwald; Adrian F Hernandez; Barry A Borlaug; G Michael Felker Journal: J Am Heart Assoc Date: 2018-12-18 Impact factor: 5.501